NCT01469819View on ClinicalTrials.gov

Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Chronic Idiopathic Constipation
Interventions
DRUG

Lubiprostone

24 mcg twice a day (BID) for 2 weeks.

Trial Locations (1)

79905

Texas Tech University Health Sciences Center, El Paso

All Listed Sponsors
collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

lead

Texas Tech University Health Sciences Center, El Paso

OTHER

NCT01469819 - Lubiprostone Effect on Gastrointestinal Tract Transit Times Measured by Smartpill in Patients With Chronic Constipation | Biotech Hunter | Biotech Hunter